Nuran Inc

Okogen Inc. is a clinical stage ophthalmic pharmaceutical company focused on innovating treatments for Acute Infectious Conjunctivitis, also known as pink eye. Their lead product is currently in Phase 2B clinical trials and aims to provide a comprehensive solution for all forms of this condition, which can be caused by bacterial and viral infections. The company highlights the significant market opportunity in the conjunctivitis sector, valued at $4.2 billion annually and projected to grow substantially. With the majority of treatments currently relying on antibiotics, Okogen is dedicated to addressing the unmet needs for effective therapies, particularly for adenoviral conjunctivitis, which accounts for 90% of viral ocular infections. Generated from the website

Escalier Biosciences is a biotechnology company based in Encinitas, CA that focuses on developing innovative therapies for various medical conditions. Specializing in research and development, Escalier Biosciences is dedicated to advancing scientific discoveries to improve patient outcomes and quality of life. Generated from their business information

Kiora Pharmaceuticals, Inc. is a biotechnology company based in Encinitas, California, dedicated to developing advanced therapies for vision-threatening retinal diseases. The company focuses on innovative small molecules to address critical pathways in conditions that currently have limited or no effective treatments. With a strong commitment to restoring and preserving vision, Kiora Pharmaceuticals is actively engaged in clinical trials to advance its pipeline products, KIO-301 and KIO-104. The company aims to slow, stop, or even reverse vision loss through its cutting-edge scientific approach. Generated from the website